Cancel

Overcoming Nursing Management Challenges in Metastatic Castration-Resistant Prostate Cancer

STATEMENT OF NEED Prostate cancer is the most common tumor type affecting men in the United States. An estimated 268,490 new cases are diagnosed annually, and 34,500 people die of the disease (ACS, 2022). Typically, androgen deprivation therapy (ADT) is administered for progressive disease. However, castration resistance or unresponsiveness to ADT or antiandrogens frequently develop over time. Nonmetastatic castration-resistant prostate cancer (CRPC) is a highly heterogeneous disease proces...
i3 Health

Novel Androgen Deprivation Treatment for Advanced Prostate Cancer: Optimizing Benefits, Mitigating Risk

Target Audience This activity is designed to meet the educational needs of medical oncologists, nurse practitioners, and other healthcare professionals who care for patients with prostate cancer. Program Overview Join Drs. Robert Dreicer and Michael Cookson as they review the principles of androgen deprivation therapy and discuss the latest clinical data for recently approved ADT agents and studies of ADT-based combination regimens in the treatment of men with metastatic hormone sensitive...
Annenberg Center for Health Sciences at Eisenhower

The ABC(DE) of ADTs in Advanced Prostate Cancer

Prostate cancer is the most common cancer in men in the U.S., responsible for an estimated 248,530 new cases and 34,130 deaths in 2021. For patients diagnosed with advanced prostate cancer, androgen deprivation therapy (ADT) plays a major role in treatment but may be associated with a broad range of adverse effects. Of these, increased risk of cardiovascular (CV) events is among the most serious, as cardiovascular disease (CVD) is the most common non-cancer cause of death in patients with pros...
University of Cincinnati

Individualizing Prostate Cancer Treatment: Special Considerations for Gay and Bisexual Men

This activity features a panel consisting of an oncologist and leading experts (a urologist and a researcher) in prostate cancer care considerations in gay and bisexual men (GBM), where they discuss quality of life considerations and disparities. The panel’s aim is to provide clinicians with real-world strategies to facilitate optimal communication and shared decision-making with these patients. This initiative provides the latest epidemiological and clinical data, controversies, and evolvin...
ACHL

Penn Radiology Oncologic Imaging Essentials (Online Streaming & DVD-ROM)

Penn Radiology responds to the constant challenge of Cancer imaging with Oncologic Imaging Essentials. This activity includes a review of the diagnostic imaging evaluation of common tumors, including breast, head and neck, thoracic and abdominal malignancies. Current state of the art modalities used for oncologic imaging, including CT, MRI, ultrasound, PET-CT and digital mammography will be discussed. Emphasis is placed on the role of imaging in staging, treatment and follow up in order to ...
Meetings By Mail®

Office Practice of Primary Care Medicine 2023 - LIVE STREAMING

The Comprehensive 2023 Update on Office-Based Primary Care Medicine OVERVIEW Office Practice of Primary Care Medicine, among the highest-rated Harvard Medical School CME courses, provides comprehensive reviews of the most important recent advances impacting primary care medicine and guidance to assimilate these changes into practice for state-of-the-art care. Education is practical and results-focused, structured to help you optimize your approach to the wide array of conditions seen in pr...
Harvard Medical School

Prostate Cancer: The future of PARP inhibitor combination and the evolving paradigm of treatment strategies

Target Audience Oncologists, physician assistants, nurse practioners, pharmacists and other healthcare professionals involved in the treatment of prostate cancer. Program Overview The overall objective for this program is to improve both the knowledge and competence of healthcare professionals who manage patients with prostate cancer using PARP-inhibitor Combination Treatments. Learning Objectives Upon completion of this activity, participants should be better able to: Discus...
Purdue University

Hormone Sensitive Prostate Cancer " Therapeutic Approaches

TARGET AUDIENCE: This activity is designed to meet the educational needs of urologists, medical oncologists, radiation oncologists and other health care professionals responsible for treatment decisions for patients with prostate cancer. Health-care professionals may be unfamiliar with the concept of patient-centered care models that provide optimal outcomes for patients with prostate cancer. PROGRAM OVERVIEW: Module 1 covers a review of current recommendations based on NCCN guidelines for ...
Purdue University College of Pharmacy

Treatment Paradigms in Advanced Prostate Cancer: Exploring the Role of PARP Inhibitor Combinations

Target Audience This activity is designed to meet the educational needs of medical oncologists, urologic oncologists, nurse practitioners, PAs, nurses and other healthcare professionals who manage patients with mCRPC. Program Overview A focused online module that examines the mechanistic rationale, discusses the latest evidence, and explores the potential role of PARP inhibitor-based combination therapy in the treatment of patients with advanced prostate cancer. Learning Objectives...
Postgraduate Institute for Medicine and Catamount Medical Education.

Nursing Management of Bone Health in Patients with Cancer

Once it has metastasized to the skeletal system, cancer often negatively affects bone health, leading to pain, fractures, hypercalcemia, and nerve compression. This online activity reviews interventions to reduce morbodity and mortality of bone complications in patients with cancer. STATEMENT OF NEED Advanced-stage cancers, including lung, breast, prostate, and multiple myeloma, can have a detrimental effect on bone health (Coleman, Croucher et al, 2020). Once cancer spreads to the skel...
i3 Health

New Vistas in Prostate Cancer Imaging (Streaming Online & USB Drive)

As the need to identify and treat prostate cancer increases, imaging is a critical tool in its diagnosis, staging and surveillance. New Vistas in Prostate Cancer Imaging is designed to help radiologists, oncologists, radiation oncologists and urologists master this continually evolving technology. This activity analyzes the two most promising imaging modalities for prostate cancer: multiparametric MRI and PSMA PET/CT. Essential concepts and multiple cases in both modalities are reviewed throug...
Meetings By Mail®

Nuclear Medicine and Molecular Imaging Update

The Mid East Chapter of the Society of Nuclear Medicine and Molecular Imaging’s historic 50th Annual Conference presents nuclear medicine’s latest trends, advances and procedures. Adapted for the enduring material audience, Nuclear Medicine and Molecular Imaging Update features a dozen faculty members presenting this specialty’s impact on imaging, cardiology, neurology, endocrinology, oncology, rheumatology, pediatrics and much more. Practice enhancements and professional development w...
Meetings By Mail®

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map